drugset / Trial / NCT03329443

The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography

NCT03329443

RandomizedParallel-groupQuadruple-blindPrevention

Summary

an interventional study to measure the possible effects of spironolactone ( an aldosterone antagonist) on the incidence of acute kidney injury after coronary angiography

Timeline

Start
2017-09-01
Primary completion
2018-09-01
Completion
2018-09-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Spironolactone Small molecule 200 mg